Novel Diagnostics Methods Driving The European Cancer IVD Market Towards Early Detection And Prevention

Early detection is the key focus of cancer diagnostics. Traditional testing methods such as immunoassay testing are facing fierce competition from evolving segments such as nucleic acid amplification technology (NAT) and immunohistochemistry testing. The ability to prove the clinical utility and practical use of the test within a laboratory is one of the essential requirements to be successful in this market.

More: continued here

Filed under: Cancer on February 25th, 2009